Earlier this week, life sciences venture firm Dimension Capital announced it had raised a new $500 million second fund ' just two years after its first ' to hunt for startups that are using artificial intelligence to develop new medicines. Venture funding to AI-related biotech and healthcare startups hit only $4.8 billion in 2023, a significant decrease from 2022. But in 2024, funding to the area has bounced back ' with such startups raising $6.7 billion through early December, per Crunchbase data. !function(e,n,i,s){var d="InfogramEmbeds";var o=e.getElementsByTagName(n)[0];if(window[d]&&window[d].initialized)window[d].process&&window[d].process();else if(!e.getElementById(i)){var r=e.createElement(n);r.async=1,r.id=i,r.src=s,o.parentNode.insertBefore(r,o)}}(document,"script","infogram-async","https://e.infogram.com/js/dist/embed-loader-min.js"); While you might think the general fervor around all things artificial intelligence means 2024 is a new high for the...
learn more
